TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Karo Pharma AS
Closing information (x1000 DKK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
452,630
|
375,975
|
287,880 |
Financial expenses |
6,538
|
3,648
|
3,617 |
Earnings before taxes |
89,154
|
104,342
|
76,199 |
Total assets |
269,199
|
282,236
|
199,781 |
Current assets |
239,024
|
247,487
|
159,610 |
Current liabilities |
164,442
|
166,215
|
105,112 |
Equity capital |
104,756
|
113,886
|
92,800 |
- share capital |
4,802
|
5,069
|
4,809 |
Employees (average) | 22 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
38.9%
|
40.4%
|
46.5% |
Turnover per employee | 13,085 | ||
Profit as a percentage of turnover |
19.7%
|
27.8%
|
26.5% |
Return on assets (ROA) |
35.5%
|
38.3%
|
40.0% |
Current ratio |
145.4%
|
148.9%
|
151.8% |
Return on equity (ROE) |
85.1%
|
91.6%
|
82.1% |
Change turnover |
96,403
|
72,583
|
-25,571 |
Change turnover % |
27%
|
24%
|
-8% |
Chg. No. of employees | 0 | ||
Chg. No. of employees % | 0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.